ArticleEuropean heart journal. Cardiovascular pharmacotherapy2026

VESALIUS keeps revolutionizing medicine: the case of evolocumab in primary prevention.

Mattia Galli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.